The Genetics Podcast

EP 266: How patient communities are accelerating rare disease research with Tania Simoncelli of Biohub

19 Nov 2026 · 47:55
Natural Sciences

Description

This week on The Genetics Podcast, Patrick is joined by Tania Simoncelli, Vice President of Translational Impact and Engagement at Biohub. They discuss how patient-led organizations drive rare disease research, the capacity building and partnerships behind the Rare As One network, how AI could change drug repurposing and clinical trials, and Tania’s role in the ACLU case against human gene patents.

Show Notes

0:00 Intro to The Genetics Podcast

00:59 Welcome to Tania

01:41 The founding story and aim of the Rare As One Project

05:17 Impact and scale of the Rare As One network, from funding to clinical trials

10:45 Why cycle four focuses on rare respiratory, immune dysregulation and sarcoma communities

14:54 How rare disease data and patient networks connect to Biohub’s virtual cell and AI models 

19:00 The Rare As One partnership with Every Cure on AI-driven drug repurposing 

24:29 Rare As One partnerships with the Broad Institute, Citizen Health and the Fowler lab

28:49 Organizational and scientific capacity building for patient-led rare disease organizations

34:03 Tania’s ACLU case against human gene patents and its impact 

43:26 How patient communities are adopting AI and where it could take rare disease research

46:33 Closing remarks

Comments

No comments yet — be the first to write one.